The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
All the companies below have large American divisions - take your pick.
James Cheek has previously worked for three of the worlds leading diagnostic companies. That is:
Cepheid - Revenue for 2022 - $4.3 Billion
Beckman Coulter - Revenue for 2022 - $4.7 Billion
Roache Diagnostics Division - Revenue for 2022 - $17.7 Billion
In roles within these companies he had extensive involvement in selling directly to the NHS. Additionally, his experience from being a Director of the British In Vitro Diagnostic Association (BIVDA) should prove invaluable, given this organisations close working relationships and previous collaborations with the NHS.
GLA.
Stephen11.
Can i just echo the valid point about AIM share prices being driven by sentiment - two examples below:
- May 5th 2020: GDRs SP was £2.19 (on the rumour of the COVID test - the government opted for inferior Chinese tests, but that's another story)
- Feb 12th May 2021: GDRs SP was £1.48 (on the back of the Beckman Coulter deal and FDA application for the COVID test, although unfortunately the Americans preferred their own tests).
The difference now is we have world firsts, in the AHIL and Stroke tests operating in a much less saturated market place.
The future is bright.
Stephen11.
Https://ndau-maps.github.io/UnitMap2020/
Here is a map of all the neonatal units in the UK. Wouldn’t it be great to have an MTRNR1 test machine in each location.
It will happen through commissioning some day 😊.
GLA.
Stephen11.
Let's not forget that the MTRNR1 test can and has saved children from lifelong hearing loss as it prevents adverse drug reactions from certain medications that premature babies may require. The test allows for an alternative and more suitable medication to be administered within a speedy, yet critical time frame. It's also the only test of its kind in the world.
I'm thinking that irrespective of full NICE accreditation we may see a type of de-facto adoption when between 5 and 10 NHS Trusts acquire the test around the UK.
Let's think about this!?
If Manchester, Brighton, Edinburgh, and Belfast Trusts were saving children from lifelong hearing loss it would be extremely unfair if premature babies from neighboring Trusts (Liverpool, Kent, Glasgow, or Craigavon) didn't have access to the same test. In this sense after a certain amount of adoption and success, the test should sell itself.
GLA.
Stephen11
Interesting conversation thread this morning, but to add balance, take note of what James Cheek said about the specialist commissioning of the MTRNR1 Test - the "100% clarity its happening" comment in particular.
From 23 minutes onwards in the GDR investormeetcompany presentation James Cheek is speaking about early adoption of the MTRNR1 hearing loss test through the NHS Special Commissioning programme.
He states "Pretty much got absolute 100% clarity that it is happening...big driver is to make sure it happens as quickly as possible." For the cynics amongst you, please listen to the presentation.
What is Special Commissioning? (info taken from NHS website)
- Special Commissioning is used to ensure smaller population have access to adequate medical provision to meet their specific needs. The population size can be as low as a few thousand or as many as 100,000
* Massive tick for GDR as there are 60,000 premature babies born in the UK per year
- Certain cohorts of the products and populations are prioritised for special commissioning. These include babies, infants, and children
* Massive tick for GDR
- The NHS 2022/23 budget for special commissioning was 22.9 billion and is increasing in 2023/23
* Massive tick for GDR
In a de facto manner Special Commissioning could be as good as full NICE accreditation.
GLA.
Stephen11.
The 600,000 drawdown.
This would indicate a placing is not imminent, as some would suggest.
Yes, money will be required at some stage for FDA submission, though it might not be in the month of January.
News due on multiple fronts so it could prove to be a very exciting month.
GLA.
Stephen11.
Wait till we start to get drill results on the gold, more lithium drill results, and updates on the plant - 2024 should be a blinder.
In context - Kodal own gold resources that are approximately 3 times the size of the Isle of man!
Detailed breakdown below:
Names and numbers for the Gold concessions in Cote d'Ivoire and Corvette
Corvette:
PR-399 212 Km² (NIELLE)
PR400 396.761 Km² (M’BIHIAKRO)
PR-398 229.02 Km² (TIEBISSOU)
International Goldfields Cote d’Ivoire
PR0834 394.7647Km² (BOUNDIALI)
PR-427 200.4052Km² (KORHOGO)
PR-426 220.7688 Km² (DABAKALA)
Obviously, i would presume the gold will not be evenly distributed amongst this land and the ongoing testing will be needed to identify the best ground - but its vast!
GLA.
Stephen11.
I am quietly optimistic that 2024 will be a dramatically better year for GDR.
These types of stocks can be marred by lengthy testing and validation, as has happened with GDR.
The difference is we now have a CEO in place with a proven track record in the sales and commercialisation of pharmocogenic devices. News due on multiple front between now and the end of January.
All stocks are a risk, but this stock is a diamond in the rough, and a risk I am happy live with.
Happy Christmas and New Year to all.
Stephen11.
Thanks bigAl67,
Yes, it was a good question you raised about the 1.2m....strange we are not getting the full amount!
If it was me i would concentrate on selling the two world beating products that we have and reduce the R+D costs by putting new products on hold for a while until we get commercial traction. I too thought Shaw was eluding to this in March 2023 - was a figure of £275, 000 per month not muted from memory?
All the best,
Stephen11.
Thanks Tiddlerontheroof and bigAl67.
Hope your keeping well bigAl67,
Could i ask a favour? When your schedule permits could you post a little synopsis of GDRs current cash position?...you always have an accurate gauge over the figures. Its just i was was seeing a lot of misinformation being posted earlier, by Starresnstoff and the likes.
GLA.
Stephen11.